Login / Signup

Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical Studies.

Jürgen BehrSteven D NathanUlrich CostabelCarlo AlberaWim A WuytsMarilyn K GlassbergHarold HallerGiuseppe AlvaroFrank GilbergKaterina SamaraLisa Lancaster
Published in: Advances in therapy (2023)
ASCEND (NCT01366209), CAPACITY 004 (NCT00287716), CAPACITY 006 (NCT00287729), RECAP (NCT00662038), PASSPORT (NCT02699879), and SP-IPF (NCT02951429).
Keyphrases
  • idiopathic pulmonary fibrosis
  • interstitial lung disease
  • systemic sclerosis